Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19

PHASE4CompletedINTERVENTIONAL
Enrollment

235

Participants

Timeline

Start Date

February 2, 2021

Primary Completion Date

March 9, 2022

Study Completion Date

February 23, 2023

Conditions
Covid19ARDS
Interventions
DRUG

Dexamethasone

Patients in the intervention group after randomization will receive dexamethasone 20 mg intravenously once daily on day 1-5, followed by dexamethasone 10 mg intravenously once daily on day 6-10. If successful extubation occurs before day 10, treatment with dexamethasone is withdrawn.

Trial Locations (1)

62500

University Hospital Brno, Brno

All Listed Sponsors
collaborator

Masaryk University

OTHER

collaborator

Vascular surgery, University hospital Královské Vinohrady, Prague

OTHER

collaborator

General University Hospital, Prague

OTHER

collaborator

University Hospital Ostrava

OTHER

collaborator

St. Anne's University Hospital Brno

UNKNOWN

collaborator

Motol University Hospital

OTHER

collaborator

University Hospital Olomouc

OTHER

collaborator

University Hospital Plzeň

UNKNOWN

collaborator

Tomáš Baťa Regional Hospital

UNKNOWN

collaborator

Military University Hospital Praha

UNKNOWN

lead

Brno University Hospital

OTHER

NCT04663555 - Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19 | Biotech Hunter | Biotech Hunter